Back to Trials
NCT04567706RecruitingAccepts Healthy Volunteers

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

Ohio State University Comprehensive Cancer Center

Start Date

5/7/2013

Completion Date

10/31/2027

Summary

This study collects and stores blood and tumor samples from patients with malignant melanoma and healthy individuals. The purpose of this study is to gain a better understanding of the causes of melanoma and how melanoma tumors behave. Storing blood and tumor samples for future research may lead to new discoveries that may ultimately help with diagnosing or treating this disease.

Detailed Description

PRIMARY OBJECTIVE: I. Facilitate studies aimed at investigating new prognostic markers and potentially therapeutic therapies in malignant melanoma. OUTLINE: Patients undergo collection of blood samples at the time of the initial diagnostic work-up, and possibly prior to the initiation of surgery, chemotherapy, immunotherapy, or radiation therapy, at tumor progression or recurrence, and annually during routine follow-up (no more than 4 blood draws per year). Patients may also undergo collection of tissue sample during standard of care surgical or radiologic procedures. Healthy individuals undergo collection of blood samples up to 4 times over 1 year.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Patient with malignant melanoma or personal history of melanoma * Normal donors * Informed consent can be obtained * Patients with any stage of malignant melanoma Exclusion Criteria: * Incarcerated individuals will be excluded from this protocol

Interventions

PROCEDURE

Biospecimen Collection

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Melanoma

Locations

Ohio State University Comprehensive Cancer Center

Columbus, Ohio 43210

United States